China Allergy Therapeutics Market was valued at $1865 Mn in 2022 and is estimated to reach $3426 Mn in 2030, exhibiting a CAGR of 7.9% during the forecast period. The need for allergy treatment drugs is being driven by the rising prevalence of allergic disorders and the related health problems. Jiangsu Hengrui Medicine Co., BeiGene, CSPC Pharmaceutical Group Co., Yunnan Baiyao Group Co., Sinopharm Group Co., Guangzhou Fuluo Pharmaceutical Co., Hunan Haier Pharmaceutical Co., Shandong Lukang Pharmaceutical Group Co., North China Pharmaceutical Group Corporation and Shanghai RAAS Pharma Co. are the leading pharmaceutical companies that are presently operating in the market
China Allergy Therapeutics Market was valued at $1865 Mn in 2022 and is estimated to reach $3426 Mn in 2030, exhibiting a CAGR of 7.9% during the forecast period.
Environmental substances known as allergens occasionally trigger an immunological reaction called allergy. Common allergens include dust mites, pollen, mildew, and certain foods, including milk, eggs, soy, and almonds. From minor symptoms like a runny nose and itchy eyes to more dangerous ones like anaphylaxis, which can result in unconsciousness and breathing difficulties, allergy reactions can take many different forms. Immunotherapy, avoiding allergens, and prescription drugs such as nasal corticosteroids and antihistamines are a few possible treatment choices.
The incidence of food allergies in China ranges from 4.0% to 8.2%, with individual prevalences of 1.9%, 1.5%, 1.4%, 1.3%, and 1.3% for regularly identified allergic foods like mango, shrimp, egg, milk, and crab, respectively. About 23.2% of urban children and 17.6% of adults in big cities suffer from allergic rhinitis (AR), a condition that is more common in northern than southern regions. Asthma prevalence is higher in urban than rural settings, affecting 4.2% of adults and 6.6% of children in urban areas nationally. Cases of atopic dermatitis (AD) are rising by 25.65% in China, outpacing the global average. Atopic dermatitis affects 34.1% of children in metropolitan areas. Adults have an overall incidence of food allergies ranging from 4.0% to 8.2%; however, children have an increased prevalence from 3.5% to 11.1%. Common allergens include milk, crab, shrimp, mango, and eggs.
A major advancement was announced by China Biologic Products, Inc. (CBP) on the phase II clinical trial results for CB010, a long-acting recombinant humanized anti-IgE antibody intended to treat severe persistent allergic rhinitis (SAR). The trial results, which are expected to be released in early 2024, could potentially advance therapy choices for this difficult allergy illness.
With the successful conclusion of phase II clinical trials for JS016, a recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) created for the treatment of peanut allergy, Shanghai Junsun Pharmaceuticals accomplished an impressive feat. The business is about to start phase III trials, which is an important step toward possible improvements in the treatment of peanut allergies.
Market Growth Drivers
Prevalence of Allergies: The demand for efficient allergy treatment medications is developing due to an increase in the prevalence of respiratory allergies and allergic disorders, including hay fever. Increased allergy prevalence may be attributed to urbanization, lifestyle changes, and environmental causes.
Rapid Urbanization and Environmental Changes: Urbanization and environmental changes, particularly pollution and exposure to new allergens, can contribute to an increased incidence of allergies. The need for allergy treatment drugs is being driven by the possibility of an increase in allergic reactions as more individuals relocate to metropolitan regions.
Advancements in Allergen Immunotherapy (AIT): The development of innovative substitutes, such sublingual immunotherapy (SLIT) patches and pills, raises the prospect of more durable relief with fewer side effects. This opens up new market niches for these innovative therapies.
Market Restraints
Long-Term Treatment Commitment: Allergen immunotherapies sometimes require a long-term commitment, ranging from months to years, in order to achieve the optimum benefits. This may be challenging for people who struggle to follow treatment programs or who might not see relief straight away.
High Cost of Treatment: Some people may find allergy treatment to be expensive due to its high cost, particularly when it comes to AIT techniques like immunotherapy injections and SLIT tablets. This could limit business penetration and accessibility. Many of the most effective allergy medications currently available, such as biologics and sublingual immunotherapy, are unaffordable for a sizable section of the population due to their high cost. Patients may not receive the best care possible as a result of the pricing barrier since fewer medications will be approved by the market.
Cultural and Behavioural Factors: Some communities preference for conventional drugs or home remedies over modern therapies may hinder market penetration. Reduced community awareness may make it more difficult to recognize and understand allergy symptoms, which could delay diagnosis and treatment. Using non-pharmaceutical techniques, such as air filters, to reduce allergens and/or eliminate allergy symptoms is becoming more popular despite these disadvantages.
In order to guarantee the safety and effectiveness of pharmaceuticals, especially allergy treatments, the National Medical Products Administration (NMPA), a crucial regulatory organization, oversees their approval, registration, and post-market surveillance. Before approving a product for marketing, the NMPA division's Center for Drug Evaluation (CDE) performs extensive evaluations. The National Health Commission (NHC), which formerly comprised the Ministry of Health (MOH), is involved in the development of healthcare policies and strategic planning. A division of NMPA, the China National Drug Administration (CNDA) is responsible for overseeing drug registration and adherence to legal requirements. The reimbursement policies that affect market access for allergy treatment pharmaceuticals are determined in part by the National Healthcare Security Administration (NHSA) and the Healthcare Security Administration (HSA).
Key Players
1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Treatment Type
By Type of Allergy
By Route of Administration
By Distribution Channel
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
This report addresses
Need more?